Results 181 to 190 of about 181,956,994 (291)

REVEL: A randomized, double-blind, phase III study of docetaxel (DOC) and ramucirumab (RAM; IMC-1121B) versus DOC and placebo (PL) in the second-line treatment of stage IV non-small cell lung cancer (NSCLC) following disease progression after one prior platinum-based therapy.

, 2014
50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, ILAmer Soc Clin ...
Kowalyszyn, Ruben Carlo, Oriov, Sergey, Garon, Edward B., Chouaki, Nadia, Lewanski, Conrad R., Alexandris, Ekaterine, Goksel, Tuncay, Zimmerman, Annamaria, Kowalyszyn, Dario, Czyzewicz, Grzegorz, Pikiel, Joanna, Arrieta, Oscar, Syrigos, Konstantinos N., John, William J., Goeksel, Tuncay, Yurasov, Sergey, Orlov, Sergey, Park, Keunchli, Zimmerman, Annemaria, Perol, Maurice, Prabhash, Kumar, Ciuleanu, Tudor-Eliade, Park, Keunchil   +22 more
core  

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit, Maaike van Dartel, Laura Rodwell, Hanneke van der Woude, Cornelis Boersma, Peter G. M. Mol, Doranne Hilarius   +6 more
wiley   +1 more source

2024 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium Meeting highlights. [PDF]

Can Urol Assoc J
Graham J, Fallah-Rad N, Kolinsky M, Morgan S, Shayegan B.   +4 more
europepmc   +1 more source

Meeting report from the 2020 Annual (virtual) Meeting of the American Society of Clinical Oncology. [PDF]

Gynecol Oncol, 2020
Salani R, Liu JF.
europepmc   +1 more source

Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice Standards

Clinical Pharmacology &Therapeutics, EarlyView.
Integrative oncology (IO) programs are committed to offer evidence‐based complementary medicine within conventional cancer care, addressing quality of life‐related concerns. As part of a multidisciplinary team, clinical pharmacists provide guidance on potential effectiveness and safety of herbal supplement use, identifying potential toxicities and herb–
Eran Ben‐Arye, Sunita Vohra, Noah Samuels, Alexandre Chan   +3 more
wiley   +1 more source

Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data. [PDF]

JTO Clin Res Rep
Behera M, Joseph G, Rupji M, Huang Z, Bunn B, Wynes MW, Switchenko J, Scagliotti GV, Tsao MS, Belani CP, Sequist LV, Ramalingam SS.   +11 more
europepmc   +1 more source

Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020. [PDF]

J Clin Med, 2020
Devarakonda S, Cottini F, Bumma N, Khan A, Sharma N, Chaudhry M, Benson D, Rosko A, Efebera Y.   +8 more
europepmc   +1 more source

Two Pillars of My Path in Cytopathology: Mentorship From Training to Practice

Diagnostic Cytopathology, EarlyView.
ABSTRACT Mentorship has been a cornerstone of my professional development in cytopathology, shaping both my diagnostic acumen and academic identity. Under the guidance of Dr. Claire Michael during residency and fellowship, I was introduced to a culture of intellectual rigor, systems thinking, and continuous improvement.
Hamza N. Gokozan
wiley   +1 more source

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. [PDF]

Neuro Oncol
Wilcox JA, Chukwueke UN, Ahn MJ, Aizer AA, Bale TA, Brandsma D, Brastianos PK, Chang S, Daras M, Forsyth P, Garzia L, Glantz M, Oliva ICG, Kumthekar P, Le Rhun E, Nagpal S, O'Brien B, Pentsova E, Lee EQ, Remsik J, Rudà R, Smalley I, Taylor MD, Weller M, Wefel J, Yang JT, Yang JT, Young RJ, Wen PY, Boire AA.   +29 more
europepmc   +1 more source

Dr. Sara E. Monaco: A Mentor Extraordinaire Who Changed Cytopathology in Rural Pennsylvania by “Making It the Best”

Diagnostic Cytopathology, EarlyView.
ABSTRACT This report introduces Dr. Sara E. Monaco, the incoming President‐Elect of the American Society of Cytopathology (ASC) and System Director of Cytopathology at Geisinger Medical Center. Dr. Monaco has provided significant mentorship to me over the years and facilitated the development of my passion for cytopathology and education.
Terrance J. Lynn
wiley   +1 more source